DND1 Antikörper (Middle Region)
Kurzübersicht für DND1 Antikörper (Middle Region) (ABIN951954)
Target
Alle DND1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 197-226, Middle Region
-
Spezifität
- This antibody recognizes Human DND1 (Center).
-
Aufreinigung
- Affinity Chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide between 197-226 amino acids from the Central region of Human DND1
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- DND1 (Dead End Homolog 1 (DND1))
-
Andere Bezeichnung
- DND1 / RBMS4
-
Hintergrund
- This gene encodes a protein that binds to microRNA-targeting sequences of mRNAs, inhibiting microRNA-mediated repression. Reduced expression of this gene has been implicated in tongue squamous cell carcinoma. Two pseudogenes of this gene are located on the long arm of chromosome 17.Synonyms: Dead end protein homolog 1, RNA-binding motif single-stranded-interacting protein 4
-
Molekulargewicht
- 38687 Da
-
Gen-ID
- 373863
-
NCBI Accession
- NP_919225
Target
-